These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

791 related items for PubMed ID: 3668980

  • 1. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM, Malamet R, Wise RA.
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [Abstract] [Full Text] [Related]

  • 2. Digital pressure and flow measurement upon local cooling in Raynaud's disease. Effect of naftidrofuryl.
    Bounameaux HM, Hellemans H, Verhaege R.
    Int Angiol; 1986 Aug; 5(1):39-44. PubMed ID: 3734514
    [Abstract] [Full Text] [Related]

  • 3. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
    Maricq HR, Weinrich MC, Valter I, Palesch YY, Maricq JG.
    J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
    [Abstract] [Full Text] [Related]

  • 4. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP.
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [Abstract] [Full Text] [Related]

  • 5. [Hemodynamic response of the digital artery to heat and cold in normal subjects, in systemic scleroderma and in Raynaud's disease].
    Vayssairat M, Mathieu JF, Housset E.
    J Mal Vasc; 1984 Sep; 9(1):7-10. PubMed ID: 6707534
    [Abstract] [Full Text] [Related]

  • 6. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA, Mellinger S, Kohler J, Dorsey JK, Furst DE.
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Raynaud's phenomenon with captopril.
    Tosi S, Marchesoni A, Messina K, Bellintani C, Sironi G, Faravelli C.
    Drugs Exp Clin Res; 1987 Aug; 13(1):37-42. PubMed ID: 3297593
    [Abstract] [Full Text] [Related]

  • 8. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
    Yocum DE, Hodes R, Sundstrom WR, Cleeland CS.
    J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523
    [Abstract] [Full Text] [Related]

  • 9. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
    Vayssairat M, Blaison N, Baudot N, Evenou P, Gilard M, Mathieu JF.
    J Mal Vasc; 1989 Feb; 14(4):299-302. PubMed ID: 2584886
    [Abstract] [Full Text] [Related]

  • 10. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T, Komiyama T, Onozuka A, Miyata T, Shigematsu H.
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [Abstract] [Full Text] [Related]

  • 11. [Finger plethysmography for studying the blood rheological and hemodynamic components of an acrosyndrome].
    de Faucal P, Planchon B, Boudard D, Peltier P, Barrier J, Grolleau JY.
    J Mal Vasc; 1986 Apr; 11(4):356-61. PubMed ID: 3805897
    [Abstract] [Full Text] [Related]

  • 12. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
    Wise RA, Malamet R, Wigley FM.
    J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
    [Abstract] [Full Text] [Related]

  • 13. Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon.
    Whitmore SE, Wigley FM, Wise RA.
    J Rheumatol; 1995 Jan; 22(1):50-4. PubMed ID: 7699682
    [Abstract] [Full Text] [Related]

  • 14. Digital pressure responses to cooling in patients with suspected early vs definite scleroderma (systemic sclerosis) vs primary Raynaud's phenomenon.
    Maricq HR, Diat F, Weinrich MC, Maricq JG.
    J Rheumatol; 1994 Aug; 21(8):1472-6. PubMed ID: 7983649
    [Abstract] [Full Text] [Related]

  • 15. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT, Valente Coimbra AM.
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [Abstract] [Full Text] [Related]

  • 16. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
    Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H.
    J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997
    [Abstract] [Full Text] [Related]

  • 17. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J, Rovenský J, Tauchmannová H, Zitnan D.
    Drugs Exp Clin Res; 1985 Apr; 11(9):659-63. PubMed ID: 3916837
    [Abstract] [Full Text] [Related]

  • 18. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease].
    Yokota S, Kuriyama T, Takahashi Y, Mori M, Shike H, Ibe M, Mitsuda T, Aihara Y.
    Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385
    [Abstract] [Full Text] [Related]

  • 19. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients.
    Pistorius MA, Planchon B, de Faucal P.
    Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791
    [Abstract] [Full Text] [Related]

  • 20. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R, Shariat K, von Wilmowsky H, Böhm M.
    Circulation; 2005 Nov 08; 112(19):2980-5. PubMed ID: 16275885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.